ARCHIVES

Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited

This article is from The Cancer Letter archive.

Vol. 02 No. 22 | May 28, 1976

Download PDF Visit The Full Archive

Related Articles

How a two-faced media covered cancer: Promoting research—and cigarettes

April 29, 2022

Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers

November 21, 2014

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

NCI Nears Confrontation Over Construction As OMB Continues Obstructionist Policies

July 11, 1975

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

July 25, 2014

House Passes 2.8 Percent Increase For NCI

December 11, 2009